Martin Rott

Associate

Email:
martin.rott@havelpartners.cz

Practice Areas:

Industry Sectors:

Martin Rott specialises in competition law, pharmaceutical law, compliance and regulation.

In competition law, Martin advises on cartels, abuse of dominance, merger clearance and foreign investment control. As part of his practice, he has represented many leading companies in proceedings before the Office for the Protection of Competition, administrative courts, and the European Commission.

In the area of pharmaceutical law, Martin focuses primarily on issues related to the distribution of medicinal products and medical devices, pricing and reimbursement regulation, and compliance. He also advises manufacturers of medicinal products and medical devices on competition issues regarding their intended projects and business strategies, including issues of dominance and abuse of dominance, setting up and changing distribution models, assessing bonus schemes and vertical agreements.  

Martin also has extensive experience in compliance advisory and has been involved in preparing and conducting competition law audits, specialised training for employees and management of major companies, and preparing compliance manuals.

Martin has been affiliated with our firm since 2017, first as a junior associate and currently as an associate.

Membership in professional associations

Czech Bar Association

Languages
Czech, English

Education

Charles University, Faculty of Law, Prague (2017), Mgr. (Master of Laws)
The University of Queensland, International Business Law (2016)
Universiteit Antwerpen, International and European Legal Studies Programme (2015-2016)

  • advising on representing a client in alleged IT cartel matters, including the subsequent proceedings before administrative courts
  • advising in proceedings before the European Commission in the field of telecommunications
  • advising a major pharmaceutical company on competition issues related to the entry of products into the Czech market
  • assessing a bonus system for a global medicinal product manufacturer, including the definition of the relevant market and analysis of potential exclusionary effects
  • advising a leading manufacturer of medicinal products and medical devices on a number of competition law issues, including analysis of the client’s market position, definition of the relevant market, and assessment of the intended strategy
  • advising a global medicinal product manufacturer on issues relating to dominance and changes in the distribution model
  • representing a client in proceedings before the Office for the Protection of Competition for merger clearance in the television broadcasting sector
  • representing a client in proceedings before the Office for the Protection of Competition concerning suspected abuse of dominance
  • representing companies in merger clearance proceedings before the European Commission
  • in-depth competition law audits of multinational companies, training for employees and management

Publications and newsletters

Czech Republic to start FDI screening from 1 May 2021
Autoři: Robert Neruda, Roman Světnický, Martin Rott A new regulation sets up a sy… read more »

Does the Directive on Unfair Trading Practices Change Anything?
Authors: Robert Neruda, Ivo Šimeček, Martin Rott The Directive on unfair trading practices in bu… read more »

Articles and Interviews

Does the Directive on Unfair Trading Practices Change Anything?
The Directive on unfair trading practices in business-to-business relationships in the agricultural… read more »